BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nosotti L, Baiocchini A, Bonifati C, Visco-Comandini U, Mirisola C, Del Nonno F. Unusual case of B cell lymphoma after immunosuppressive treatment for psoriasis. World J Hepatol 2015; 7(5): 814-818 [PMID: 25914782 DOI: 10.4254/wjh.v7.i5.814]
URL: https://www.wjgnet.com/1948-5182/full/v7/i5/814.htm
Number Citing Articles
Gautham Vellaichamy, Steven M. Townsend, Alexis B. Lyons, Iltefat H. Hamzavi. T-cell/histiocyte-rich large B-cell lymphoma in a 27-year-old with hidradenitis suppurativa, psoriasis, and vitiligo: Implications for screeningJAAD Case Reports 2020; 6(12): 1252 doi: 10.1016/j.jdcr.2020.08.032
Ju Yeon Ryoo, Hye-Jin Yang, Eunhee Ji, Bong Kyu Yoo. Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque PsoriasisAnnals of Pharmacotherapy 2016; 50(5): 341 doi: 10.1177/1060028015626545
Michihide Tokuhira, Jun-ichi Tamaru, Masahiro Kizaki. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disordersJournal of Clinical and Experimental Hematopathology 2019; 59(2): 72 doi: 10.3960/jslrt.19007
R.P.O.M. Andrade, K.W.P. Gomes, W.P. Vieira, A.J.P. Luz. LINFOMA E ESPONDILITE ANQUILOSANTE (EA) EM USO DE ANTI‐TNF: RELATO DE DOIS CASOSRevista Brasileira de Reumatologia 2017; 57: S115 doi: 10.1016/j.rbr.2017.07.080
Paul Sator. Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experienceTherapeutic Advances in Chronic Disease 2018; 9(8): 147 doi: 10.1177/2040622318772705